Bacteriostatic water is suitable for use in research settings that require measured withdrawals over time when handled in accordance with standard laboratory practices
- Not FDA-approved for human use commonly available through research and compounding pharmacies
[1] [2] However, longstanding neurological complications, such as peripheral neuropathy or cognitive changes, may require three to six months of consistent treatment before significant improvement occurs, and some damage may be irreversible if treatment is delayed
What this likely means in practice: Progressive functional improvement as tissue matures
Other Research Peptides How does BPC-157 compare to other peptides in the repair/recovery research space
On July 23, 2026, the FDAs Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding BPC-157 to the 503A Bulks List